Table 1 Demographic and baseline clinical data of study subjects
Characteristics | N (%) |
|---|---|
Age (years) | |
  ≥ 50 | 41 (66.1) |
  < 50 | 21 (33.9) |
Stage | |
 IB | 1 (1.6) |
 IIA | 5 (8.1) |
 IIB | 47 (75.7) |
 IIIA | 4 (6.5) |
 IIIB | 4 (6.5) |
 IVA | 1 (1.6) |
Risk group | |
 Low risk group | 6 (9.6) |
 High risk group | 56 (90.4) |
Maximal diameter of tumor (cm) | |
  < 3 | 8 (12.8) |
  ≥ 3 and < 4 | 14 (22.6) |
  ≥ 4 and < 5 | 12 (19.5) |
  ≥ 5 | 28 (45.1) |
Lymph node status | |
 Negative | 46 (74.2) |
 Positive | 16 (25.8) |